Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control
Crossref DOI link: https://doi.org/10.1007/s40273-014-0246-7
Published Online: 2014-12-16
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Janzic, Andrej
Kos, Mitja
Text and Data Mining valid from 2014-12-16